Christopher Davis’s Idexx Laboratories IDXX Stock Holding History

Christopher Davis’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-264,392	Closed	-$19.3M	–	174
2015 Q4	$19.3M	Sell	264,392 -359,181	-58%	-$25.6M	0.08%	77
2015 Q3	$46.3M	Sell	623,573 -110,056	-15%	-$7.88M	0.19%	51
2015 Q2	$47.1M	Buy	733,629 +22,333	+3%	+$1.55M	0.16%	47
2015 Q1	$54.9M	Buy	711,296 +7,722	+1%	+$601K	0.19%	47
2014 Q4	$52.2M	Buy	703,574 +56,584	+9%	+$3.97M	0.17%	50
2014 Q3	$38.1M	Buy	646,990 +276,478	+75%	+$17.5M	0.12%	60
2014 Q2	$24.7M	Buy	370,512 +11,354	+3%	+$722K	0.07%	74
2014 Q1	$21.8M	Buy	359,158 +20,076	+6%	+$1.2M	0.06%	81
2013 Q4	$18M	Buy	339,082 +2,196	+0.7%	+$116K	0.04%	82
2013 Q3	$16.8M	Sell	336,886 -22,702	-6%	-$1.09M	0.04%	85
2013 Q2	$16.1M	Buy	+359,588	New	+$15.7M	0.04%	101

Other funds holding IDXX

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Christopher Davis's IDXX Position: Q1 2016 in Review

Christopher Davis sold out of Idexx Laboratories (IDXX) in Q1 2016, closing a stake of 264,392 shares — an estimated $19.3M sold.

Christopher Davis first reported a position in IDXX in Q2 2013 and held it in 11 quarters. The position peaked at $54.9M in Q1 2015. 377 funds tracked by Wall St. Rank hold IDXX as of Q1 2016.

Christopher Davis reported no remaining Idexx Laboratories position as of Q1 2016 after selling out during the quarter.
Christopher Davis sold 264,392 Idexx Laboratories shares in Q1 2016, an estimated $19.3M.
Christopher Davis first reported a position in Idexx Laboratories in Q2 2013 and held it in 11 quarters.
Christopher Davis's Idexx Laboratories position peaked at $54.9M in Q1 2015.
377 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2016.

Based on Davis Selected Advisers's 13F filing for Q1 2016, filed 13 May 2016.